Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. (Q33376783)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. |
scientific article |
Statements
1 reference
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q. (English)
1 reference
H Joachim Deeg
1 reference
Robert D Knight
1 reference
Azra Raza
1 reference
James A Reeves
1 reference
Eric J Feldman
1 reference
Gordon W Dewald
1 reference
John M Bennett
1 reference
Luke Dreisbach
1 reference
Charles A Schiffer
1 reference
Richard M Stone
1 reference
Peter L Greenberg
1 reference
Peter T Curtin
1 reference
Virginia M Klimek
1 reference
Jamile M Shammo
1 reference
Deborah Thomas
1 reference
Michele Schmidt
1 reference
Kenton Wride
1 reference
Jerome B Zeldis
1 reference
Alan F List
1 reference
24 September 2007
1 reference
Identifiers
1 reference